Oligodeoxynucleotide decoy therapy blocks type 1 procollagen transcription and the prolyl hydroxylase beta subunit translation

J Cell Biochem. 2008 Mar 1;103(4):1066-75. doi: 10.1002/jcb.21477.

Abstract

Persistent transforming growth factor-beta1 (TGF-beta1) exposure to lungs increases type 1 collagen synthesis and deposition resulting in excess fibrosis which leads to morbidity and possibly death. We now report using human embryonic lung fibroblasts in the presence of TGF-beta1, a novel double-stranded (ds) DNA decoy with phosphorothioate (PT) linkages, containing the TGF-beta cis-element found in the distal promoter region of the COL1A1 gene which silences COL1A1 gene expression. In a cell-free protein translation system, we have previously reported that collagen synthesis was inhibited by disulfide isomerase, the prolyl-4-hydroxylase (P-4-H) beta subunit. By comparative proteomics dsdecoy therapy increased the levels of disulfide isomerase, the P-4-H beta subunit. These findings taken together support the notion that the dsdecoy inhibits type 1 collagen synthesis at both the transcriptional and translational levels.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Collagen Type I / biosynthesis
  • Collagen Type I / genetics*
  • Collagen Type I, alpha 1 Chain
  • Embryo, Mammalian / cytology
  • Fibroblasts / metabolism
  • Humans
  • Lung / cytology
  • Oligonucleotides / genetics
  • Oligonucleotides / pharmacology*
  • Oligonucleotides, Antisense / genetics
  • Oligonucleotides, Antisense / pharmacology
  • Procollagen-Proline Dioxygenase / biosynthesis*
  • Promoter Regions, Genetic
  • Protein Biosynthesis
  • Transcription, Genetic*
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Oligonucleotides
  • Oligonucleotides, Antisense
  • Transforming Growth Factor beta1
  • Procollagen-Proline Dioxygenase